IP Library Granted Patent US 7,987,850
Granted Patent B2
US 7,987,850 · App. 12/652,268 · Granted Aug 2, 2011

Nasal interface prong device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,987,850
App. No.
12/652,268
Granted
Aug 2, 2011
Kind
B2
Abstract

An infant nasal interface prong device for use with an nCPAP system. The device includes first and second nasal prongs and a base. Each prong includes a bellows segment, a tip, and a lumen. The tip extends from the bellows segment to a tip end and is adapted for insertion with an infant's naris. The lumen extends through the tip and the bellows segment. In an undeflected state, a central axis of the lumen along the bellows segment is transversely offset from the lumen axis at the tip end. The base is connected to each of the nasal prongs and is adapted for coupling to a CPAP generator. The bellows segment renders the corresponding prong highly flexible relative to the base. The offset positioning of the tip end promotes desired positioning of the base/CPAP generator, relative to the patient and more closely conforms to the expected nasal anatomy.

Claims (36)

1. A nasal interface prong device, the device comprising:

first and second nasal prongs each including:

a bellows segment,

a tip having a tip body extending from the bellows segment and terminating in a tip end opposite the bellows segment, the tip body including a side forming a concave curve,

a lumen extending through the prong and open at the tip end,

wherein in an undeflected state, a central axis of the lumen as defined by the bellows segment is transversely offset from a central axis of the lumen as defined by the tip end.

2. The nasal interface device of claim 1 , wherein relative to an upright orientation of the device, each prong is characterized by the central axis of the lumen as defined by the bellows segment being vertically offset from the central axis of the lumen as defined by the tip end in an undeflected state.

3. The nasal interface device of claim 1 , wherein a central axis of the first passage is transversely offset from the central axis of the first lumen defined by the corresponding tip end.

4. The nasal interface device of claim 1 , wherein the central axis of each prong is non-linear.

5. The nasal interface device of claim 1 , wherein relative to an orientation upon insertion within a naris, the tip body defines top side and a bottom side, and further wherein at least a portion of the top side forms a convex curve and at least a portion of the bottom side forms the concave curve.

6. The nasal interface device of claim 1 , wherein relative to an upright of the device, each prong is characterized by the central axis of the lumen as defined by the bellows segment being horizontally offset from the central axis of the lumen as defined by the tip in an undeflected state.

7. The nasal interface device of claim 1 , wherein each of the prongs defines an interior side relative to the opposing prong, and further wherein in the undeflected state, the interior sides are substantially parallel.

8. The nasal interface device of claim 1 , wherein the bellows segment is non-symmetrical.

9. The nasal interface device of claim 1 , wherein the bellows segment includes a plurality of sections combining to define a plurality of bends each having a bend angle, and further wherein the bellows segment is configured such that in an undeflected state, at least one of the bend angles is non-uniform about a circumference of the corresponding prong.

10. The nasal interface device of claim 9 , wherein the prongs extend in a juxtaposed fashion such that each prong defines an interior side and exterior side, and further wherein in an undeflected state, at least one of the bend angles differs at the interior side as compared to the exterior side.

11. The nasal interface device of claim 1 , wherein each bellows segment includes a trailing end opposite the tip end, and further wherein in an undeflected state, a transverse plane defined by the trailing end is not perpendicular to the central axis of the lumen at the tip end.

12. The nasal interface device of claim 1 , wherein each prong is formed by a continuous wall having a nominal thickness along the tip that is greater than a thickness of the wall along at least a portion of the bellows segment.

13. The nasal interface device of claim 1 , wherein each prong further includes a foot, and further wherein a nominal wall thickness of the foot is greater than a wall thickness along at least a portion of the corresponding bellows segment.

14. The nasal interface device of claim 13 , wherein the feet are configured to collectively define a septal relief zone.

15. The nasal interface device of claim 13 , wherein each prong is configured such that in an undeflected state, the central axis of the lumen along the foot is not parallel with the central axis of the lumen at the tip end.

16. The nasal interface device of claim 13 , wherein in an undeflected state, the central axis of the lumen along the foot is not parallel with the central axis of each lumen along the tip body.

17. The nasal interface device of claim 1 , wherein each tip end is flared relative to the corresponding tip body such that each tip end defines an increasing outer diameter with respect to a diameter of the corresponding tip body.

18. The nasal interface of claim 1 , further comprising a base connected to each of the nasal prongs and adapted for coupling to a continuous positive airway pressure generator, the base forming first and second passages fluidly connected to respective ones of the first and second lumens.

19. The nasal interface device of claim 18 , wherein the base is configured to define, in transverse cross-section, opposed first and second side edges and opposed first and second end edges, and further wherein a transition between a first end edge and the first side edge defines a curve and a transition between the first end edge and the second side edge is a corner.

20. The nasal interface device of claim 18 , wherein the base further forms a channel extending between, and fluidly connected to, the first and second passages.

21. A nasal interface device, the device comprising:

first and second nasal prongs each including:

a bellows segment,

a tip having a tip body extending from a bellows segment and terminating in a tip end opposite the bellows segment, the tip end being flared relative to the tip body so as to define an increasing outer diameter with respect to a diameter of the tip body, and

a lumen extending through the prong and open at the distal end.

22. The nasal interface device of claim 21 , wherein in an undeflected state, a central axis of the lumen as defined by the bellows segment is transversely offset from a central axis of the lumen defined by the tip end.

23. The nasal interface device of claim 21 , further comprising a base connected to each of the nasal prongs and forming first and second passages fluidly connected to respective ones of the first and second lumens, wherein the passages are fluidly connected to respective ones of the first and second tubes upon final assembly.

24. The nasal interface device of claim 21 , wherein the tip body defines a top side and a bottom side, and further wherein at least a portion of the top side forms a convex curve and at least a portion of the bottom side forms a concave curve.

25. The nasal interface device of claim 21 , wherein the first and second prongs extend in a juxtaposed fashion with the bellows segment of each of the prongs being non-symmetrical relative to an axis of the tip body.

26. The nasal interface device of claim 21 , wherein each of the prongs defines an interior side relative to the opposing prong, and further wherein, in an undeflected state, the interior sides are substantially parallel.

27. The nasal interface device of claim 21 , wherein each bellows segment includes a trailing end opposite the tip end, and further wherein in an undeflected state, a transverse plane defined by the trailing end is not perpendicular to a central axis of the lumen at the tip end.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Dec 13, 2024
From: VYAIRE MEDICAL, INC., ET AL.'S CREDITORS
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069635/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2024
From: VYAIRE MEDICAL CONSUMABLES LLC
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069455/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: ZOLLINGER, CHRIS; PIERRO, BRIAN
To: ALLEGIANCE CORPORATION
Reel/Frame 069416/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: ALLEGIANCE CORPORATION
To: CARDINAL HEALTH CMP 200, INC.
Reel/Frame 069416/0913 →
CHANGE OF NAME Recorded Nov 26, 2024
From: CARDINAL HEALTH CMP 200, INC.
To: CAREFUSION 2200, INC.
Reel/Frame 069452/0682 →
SECURITY INTEREST Recorded May 9, 2019
From: VYAIRE MEDICAL CONSUMABLES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049147/0928 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VYAIRE MEDICAL CONSUMABLES LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0940 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VYAIRE MEDICAL CONSUMABLES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045969/0830 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2018
From: CITIZENS BANK, N.A.
To: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; CAREFUSION 202, INC.; VITAL SIGNS, INC.
Reel/Frame 045779/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: CAREFUSION 2200, INC.
To: KINGSTON RESPIRATORY 102 LLC
Reel/Frame 040648/0009 →
CHANGE OF NAME Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY CONSUMABLES LLC
To: VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 040648/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY 102 LLC
To: KINGSTON RESPIRATORY CONSUMABLES LLC
Reel/Frame 040648/0047 →
SECURITY AGREEMENT Recorded Oct 14, 2016
From: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; VITAL SIGNS, INC.; CAREFUSION 202, INC.
To: CITIZENS BANK, N.A, AS COLLATERAL AGENT
Reel/Frame 040357/0952 →